Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 30 | 2024 | 3220 | 4.260 |
Why?
|
Epstein-Barr Virus Infections | 8 | 2024 | 611 | 2.150 |
Why?
|
Amyotrophic Lateral Sclerosis | 7 | 2023 | 1468 | 1.570 |
Why?
|
Parkinson Disease | 13 | 2024 | 2875 | 1.560 |
Why?
|
alpha-Linolenic Acid | 2 | 2018 | 144 | 1.130 |
Why?
|
Infectious Mononucleosis | 3 | 2016 | 133 | 1.110 |
Why?
|
Neurofilament Proteins | 4 | 2022 | 336 | 1.050 |
Why?
|
Norway | 13 | 2023 | 497 | 0.880 |
Why?
|
Fatty Acids, Unsaturated | 3 | 2023 | 540 | 0.750 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 3 | 2023 | 555 | 0.750 |
Why?
|
Herpesvirus 4, Human | 7 | 2024 | 1078 | 0.690 |
Why?
|
Smoking | 5 | 2023 | 9046 | 0.670 |
Why?
|
Registries | 7 | 2023 | 8216 | 0.550 |
Why?
|
Sunlight | 2 | 2019 | 337 | 0.540 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2018 | 269 | 0.520 |
Why?
|
Uric Acid | 2 | 2018 | 808 | 0.490 |
Why?
|
Early Diagnosis | 1 | 2020 | 1183 | 0.480 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5835 | 0.450 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2023 | 1389 | 0.450 |
Why?
|
Case-Control Studies | 17 | 2024 | 22097 | 0.440 |
Why?
|
Dietary Fats | 2 | 2020 | 1994 | 0.420 |
Why?
|
Siblings | 1 | 2016 | 825 | 0.400 |
Why?
|
Metabolome | 1 | 2019 | 986 | 0.400 |
Why?
|
Sex Characteristics | 2 | 2020 | 2633 | 0.370 |
Why?
|
Menopause | 1 | 2018 | 1645 | 0.340 |
Why?
|
Social Class | 2 | 2016 | 2003 | 0.340 |
Why?
|
Risk | 8 | 2019 | 9605 | 0.310 |
Why?
|
Disease Progression | 3 | 2023 | 13484 | 0.310 |
Why?
|
Italy | 5 | 2019 | 840 | 0.300 |
Why?
|
Risk Factors | 19 | 2024 | 74055 | 0.280 |
Why?
|
Vitamin D | 3 | 2021 | 3303 | 0.270 |
Why?
|
Female | 39 | 2024 | 391875 | 0.250 |
Why?
|
Cohort Studies | 11 | 2023 | 41366 | 0.250 |
Why?
|
Military Personnel | 3 | 2024 | 1246 | 0.250 |
Why?
|
Migraine Disorders | 1 | 2017 | 1697 | 0.240 |
Why?
|
Humans | 56 | 2024 | 760437 | 0.240 |
Why?
|
Anti-HIV Agents | 1 | 2020 | 4518 | 0.240 |
Why?
|
Antibodies, Viral | 4 | 2024 | 3155 | 0.230 |
Why?
|
Exercise | 3 | 2019 | 5874 | 0.230 |
Why?
|
Adult | 30 | 2024 | 220781 | 0.230 |
Why?
|
Middle Aged | 28 | 2024 | 220382 | 0.220 |
Why?
|
Male | 35 | 2024 | 360035 | 0.220 |
Why?
|
Follow-Up Studies | 8 | 2023 | 39078 | 0.210 |
Why?
|
Logistic Models | 5 | 2020 | 13240 | 0.210 |
Why?
|
Cotinine | 1 | 2023 | 203 | 0.210 |
Why?
|
Body Size | 2 | 2017 | 463 | 0.210 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2023 | 226 | 0.200 |
Why?
|
Age of Onset | 2 | 2022 | 3302 | 0.190 |
Why?
|
Flavonoids | 1 | 2024 | 444 | 0.190 |
Why?
|
Aged | 21 | 2024 | 168840 | 0.180 |
Why?
|
Odds Ratio | 4 | 2016 | 9639 | 0.170 |
Why?
|
Seasons | 3 | 2019 | 1518 | 0.170 |
Why?
|
Hair Color | 2 | 2023 | 131 | 0.160 |
Why?
|
Incidence | 5 | 2023 | 21322 | 0.160 |
Why?
|
Prospective Studies | 10 | 2024 | 54339 | 0.160 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 3 | 2024 | 157 | 0.160 |
Why?
|
Longitudinal Studies | 4 | 2023 | 14565 | 0.160 |
Why?
|
Toluidines | 1 | 2018 | 21 | 0.160 |
Why?
|
Crotonates | 1 | 2018 | 21 | 0.160 |
Why?
|
Educational Status | 2 | 2016 | 2518 | 0.150 |
Why?
|
HIV Infections | 2 | 2024 | 17328 | 0.150 |
Why?
|
Public Health | 1 | 2021 | 2665 | 0.150 |
Why?
|
Cytomegalovirus | 1 | 2022 | 755 | 0.140 |
Why?
|
Young Adult | 12 | 2024 | 59068 | 0.140 |
Why?
|
Cytomegalovirus Infections | 1 | 2023 | 831 | 0.140 |
Why?
|
Optic Nerve | 1 | 2020 | 572 | 0.140 |
Why?
|
Celiac Disease | 1 | 2024 | 825 | 0.130 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2017 | 214 | 0.130 |
Why?
|
Gout Suppressants | 1 | 2018 | 177 | 0.130 |
Why?
|
Folic Acid | 1 | 2023 | 1315 | 0.130 |
Why?
|
Diet | 4 | 2024 | 8058 | 0.130 |
Why?
|
Cod Liver Oil | 1 | 2015 | 9 | 0.130 |
Why?
|
Biomedical Research | 1 | 2021 | 3421 | 0.130 |
Why?
|
Fatty Acids | 1 | 2023 | 1805 | 0.120 |
Why?
|
Chromatography, Liquid | 1 | 2019 | 983 | 0.120 |
Why?
|
Cesarean Section | 1 | 2023 | 1393 | 0.120 |
Why?
|
Vaccines | 1 | 2023 | 836 | 0.120 |
Why?
|
Antiviral Agents | 2 | 2024 | 3066 | 0.120 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 1 | 2016 | 254 | 0.110 |
Why?
|
Sweden | 1 | 2017 | 1378 | 0.110 |
Why?
|
Sunscreening Agents | 1 | 2014 | 139 | 0.110 |
Why?
|
Metabolomics | 2 | 2020 | 1653 | 0.110 |
Why?
|
Body Mass Index | 3 | 2021 | 12932 | 0.100 |
Why?
|
Physical Fitness | 1 | 2017 | 739 | 0.100 |
Why?
|
Spinal Cord | 1 | 2020 | 1817 | 0.100 |
Why?
|
Mass Spectrometry | 1 | 2019 | 2189 | 0.100 |
Why?
|
Adolescent | 11 | 2021 | 88196 | 0.100 |
Why?
|
Prebiotics | 1 | 2021 | 41 | 0.090 |
Why?
|
alpha-Synuclein | 1 | 2017 | 750 | 0.090 |
Why?
|
Cholecalciferol | 1 | 2015 | 552 | 0.090 |
Why?
|
Europe | 1 | 2016 | 3419 | 0.080 |
Why?
|
Dementia | 1 | 2024 | 2679 | 0.080 |
Why?
|
Lipids | 1 | 2020 | 3342 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2018 | 1588 | 0.080 |
Why?
|
Feeding Behavior | 1 | 2020 | 3188 | 0.080 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 3202 | 0.080 |
Why?
|
Dietary Supplements | 2 | 2023 | 3405 | 0.070 |
Why?
|
Probiotics | 1 | 2021 | 378 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2020 | 4026 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15820 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2020 | 3956 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4168 | 0.060 |
Why?
|
Databases, Factual | 2 | 2018 | 7948 | 0.060 |
Why?
|
Melanoma | 1 | 2023 | 5704 | 0.060 |
Why?
|
Aging | 2 | 2021 | 8689 | 0.060 |
Why?
|
Adverse Drug Reaction Reporting Systems | 2 | 2018 | 487 | 0.060 |
Why?
|
Prevalence | 1 | 2022 | 15698 | 0.060 |
Why?
|
Adrenal Cortex Hormones | 2 | 2023 | 1874 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 3 | 2021 | 36362 | 0.060 |
Why?
|
Age Factors | 2 | 2018 | 18379 | 0.060 |
Why?
|
Risk Assessment | 2 | 2016 | 23953 | 0.060 |
Why?
|
Pesticide Residues | 1 | 2024 | 95 | 0.060 |
Why?
|
Aged, 80 and over | 3 | 2019 | 58859 | 0.050 |
Why?
|
Cholinergic Antagonists | 1 | 2023 | 168 | 0.050 |
Why?
|
Vitamin B 6 | 1 | 2023 | 234 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 10180 | 0.050 |
Why?
|
Asthma | 1 | 2019 | 6195 | 0.040 |
Why?
|
Vitamin B 12 | 1 | 2023 | 524 | 0.040 |
Why?
|
Metagenomics | 1 | 2023 | 466 | 0.040 |
Why?
|
Infant | 3 | 2019 | 36183 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 11900 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2023 | 26280 | 0.040 |
Why?
|
REM Sleep Behavior Disorder | 1 | 2020 | 108 | 0.040 |
Why?
|
HLA Antigens | 1 | 2024 | 1371 | 0.040 |
Why?
|
Body Weights and Measures | 1 | 2019 | 208 | 0.040 |
Why?
|
Fruit | 1 | 2024 | 1160 | 0.040 |
Why?
|
Vegetables | 1 | 2024 | 1195 | 0.040 |
Why?
|
Child, Preschool | 3 | 2019 | 42209 | 0.040 |
Why?
|
Carnitine | 1 | 2020 | 252 | 0.040 |
Why?
|
Hydroxybutyrates | 1 | 2018 | 79 | 0.040 |
Why?
|
Adrenergic beta-1 Receptor Agonists | 1 | 2017 | 14 | 0.040 |
Why?
|
Health Status | 1 | 2021 | 4071 | 0.040 |
Why?
|
Probability | 1 | 2023 | 2476 | 0.040 |
Why?
|
Child | 5 | 2019 | 80086 | 0.040 |
Why?
|
Colorimetry | 1 | 2017 | 148 | 0.040 |
Why?
|
Biological Assay | 1 | 2020 | 626 | 0.040 |
Why?
|
Diet, Mediterranean | 1 | 2024 | 742 | 0.040 |
Why?
|
Time Factors | 2 | 2020 | 39947 | 0.030 |
Why?
|
Albuterol | 1 | 2017 | 213 | 0.030 |
Why?
|
Plasma | 1 | 2020 | 585 | 0.030 |
Why?
|
Propranolol | 1 | 2017 | 489 | 0.030 |
Why?
|
Constipation | 1 | 2020 | 562 | 0.030 |
Why?
|
Substantia Nigra | 1 | 2017 | 350 | 0.030 |
Why?
|
Dietary Carbohydrates | 1 | 2020 | 891 | 0.030 |
Why?
|
Brazil | 1 | 2019 | 1224 | 0.030 |
Why?
|
Diet Surveys | 1 | 2019 | 1162 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13616 | 0.030 |
Why?
|
Gadolinium | 1 | 2020 | 960 | 0.030 |
Why?
|
Acetylation | 1 | 2017 | 1054 | 0.030 |
Why?
|
Food | 1 | 2019 | 772 | 0.030 |
Why?
|
Sex Distribution | 1 | 2019 | 2281 | 0.030 |
Why?
|
Canada | 1 | 2019 | 2119 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2021 | 1834 | 0.030 |
Why?
|
Age Distribution | 1 | 2019 | 2878 | 0.030 |
Why?
|
Nitriles | 1 | 2018 | 969 | 0.030 |
Why?
|
Brain | 1 | 2020 | 27060 | 0.030 |
Why?
|
Obesity | 1 | 2014 | 12918 | 0.020 |
Why?
|
Peptides | 1 | 2024 | 4338 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2017 | 1240 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2024 | 4748 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2017 | 957 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2017 | 1363 | 0.020 |
Why?
|
Ligands | 1 | 2017 | 3270 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2018 | 1663 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7208 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2024 | 12429 | 0.020 |
Why?
|
Image Enhancement | 1 | 2020 | 2882 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5865 | 0.020 |
Why?
|
United States | 3 | 2024 | 72202 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8466 | 0.020 |
Why?
|
Histones | 1 | 2017 | 2577 | 0.020 |
Why?
|
Mental Health | 1 | 2021 | 3241 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5778 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10538 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2017 | 7597 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10759 | 0.010 |
Why?
|
Liver | 1 | 2018 | 7531 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29831 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2018 | 9176 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16585 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 16945 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 13338 | 0.010 |
Why?
|
Mice | 1 | 2017 | 81402 | 0.010 |
Why?
|
Animals | 1 | 2017 | 168253 | 0.000 |
Why?
|
Concepts
(184)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(43)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_